NCT02802670View on ClinicalTrials.gov

A Pharmacokinetic Study of [14C]-GDC-0810 After Single Oral Administration in Healthy Female Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

7

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions

Healthy Volunteers

Interventions

DRUG

[14C]-GDC-0810

Participants will receive a single 300-mg dose of GDC-0810 containing approximately 100 microcuries of \[14C\]-labeled GDC-0810 on Day 1.

Trial Locations (1)

53704

Madison

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY

NCT02802670 - A Pharmacokinetic Study of [14C]-GDC-0810 After Single Oral Administration in Healthy Female Participants | Biotech Hunter | Biotech Hunter